|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 147.20 SEK | +7.76% |
|
+6.36% | -6.36% |
| 07-17 | CellaVision AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-17 | CellaVision AB, Q2 2026 Earnings Call, Jul 17, 2026 |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Automated Microscopy Systems and Reagents in The Field of Hematology | 566M | 639M | 677M | 723M | 759M | |||||
Total Assets | 825M | 892M | 929M | 1.01B | 1.09B | |||||
Interest Expense | -1.87M | -2.34M | -3.26M | -1.89M | -886K | |||||
Income Tax Expense | 32.96M | 30.09M | 33.91M | 36.14M | 41.19M | |||||
CAPEX | -84.31M | -69.43M | -31.77M | -11.99M | -18.81M | |||||
EBT | 158M | 148M | 164M | 177M | 194M | |||||
Gross Profit | 392M | 438M | 463M | 487M | 520M | |||||
D&A | 26.69M | 33.39M | 32.37M | 33.58M | 31.84M | |||||
Operating Income | 163M | 158M | 167M | 178M | 202M | |||||
Net Income | 125M | 118M | 130M | 141M | 153M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States of America (USA) | - | - | 280M | 251M | 294M | |||||
Germany | - | - | 140M | 183M | 206M | |||||
APAC | 103M | 78.9M | 86.76M | 120M | 107M | |||||
Total Assets | 832K | 366K | - | - | - | |||||
EMEA (Excl. Germany, France and Sweden) | - | - | - | 75.47M | 81.7M | |||||
France | - | - | 60.82M | 73.5M | 61.97M | |||||
Total Assets | - | - | 90.35M | 297M | 288M | |||||
Total Assets | - | - | 191K | 54K | 10K | |||||
Americas (Excl. USA) | - | - | 32.87M | 17.42M | 7.58M | |||||
Sweden | 313K | 293K | - | 2.55M | 587K | |||||
Total Assets | - | - | 34.96M | 310M | 363M | |||||
Emea (excluding France and Germany) | - | - | 76.79M | - | - | |||||
EMEA (Excluding Sweden) | 252M | 280M | - | - | - | |||||
Americas | 210M | 280M | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
EMEA | - | - | - | - | - | |||||
Total Assets | 79.49M | 110M | - | - | - | |||||
North America | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
- Stock Market
- Stocks
- CEVI Stock
- Financials CellaVision AB
- Business Segments
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
